Improving Compliance and Decreasing Drug Accumulation of Diethylstilbestrol through Cocrystallization

02 engineering and technology 0210 nano-technology 3. Good health
DOI: 10.1021/acs.cgd.8b01911 Publication Date: 2019-01-24T20:07:22Z
ABSTRACT
Diethylstilbestrol (DES), a synthetic nonsteroidal estrogen, has been prescribed for advanced breast cancer and prostate cancer. However, its poor compliance, reactive metabolite toxicity and hydro...
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (11)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....